AIFortuneabout 4 hours ago
Simo launches ChronicleBio after OpenAI exit
3 min read
Fidji Simo left OpenAI in early July and launched ChronicleBio, a startup using AI to analyze blood and segment POTS patients into granular cohorts. Simo, who has POTS, aims to make clinical drug trials more targeted and successful.
Level
Hype check
Tap to vote and see what everyone thinks.
In this storyOpenAI
Summary by ByteBrief
